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Abstract
Purpose: Severity of abdominal obesity and possibly levels ofmetabolic activity of abdominal visceral
adipose tissue (VAT) are associated with an increased risk for cardiovascular disease (CVD). In this
context, the purpose of the current study was to evaluate the reproducibility and repeatability of a
semi-automated method for assessment of the metabolic activity of VAT using 2-deoxy-2-[18F]fluoro-
D-glucose ([18F]FDG) positron emission tomography (PET)/x-ray computed tomography (CT).
Procedures: Ten patients with lung cancer who underwent two baseline whole-body [18F]FDG
PET/low-dose (LD) CT scans within 1 week were included. Abdominal VAT was automatically
segmented using CT between levels L1–L5. The initial CT-based segmentation was further
optimized using PET data with a standardized uptake value (SUV) threshold approach (range
1.0–2.5) and morphological erosion (range 0–5 pixels). The [18F]FDG uptake in SUV that was
measured by the automated method was compared with manual analysis. The reproducibility
and repeatability were quantified using intraclass correlation coefficients (ICCs).
Results: The metabolic assessment of VAT on [18F]FDG PET/LDCT scans expressed as
SUVmean, using an automated method showed high inter and intra observer (all ICCs 9 0.99) and
overall repeatability (ICC = 0.98). The manual method showed reproducible inter observer (all
ICCs 9 0.92), but less intra observer (ICC = 0.57) and less overall repeatability (ICC = 0.78)
compared with the automated method.
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Conclusions: Our proposed semi-automated method provided reproducible and repeatable
quantitative analysis of [18F]FDG uptake in VAT. We expect this method to aid future research
regarding the role of VAT in development of CVD.
Key Words: [18F]FDG, PET/CT, Repeatability, Reproducibility, Semi-automated method,
Visceral adipose tissue
Introduction
Worldwide, the prevalence of overweight and obesity is on
the rise, with more than 1.9 billion adults affected in 2016
[1]. Abdominal obesity is a major risk factor for cardiovas-
cular disease (CVD) development and premature mortality
[2, 3]. However, not all obese individuals are at high risk of
CVD [4, 5]. Abdominal adipose tissue can be divided in
visceral adipose tissue (VAT) and subcutaneous adipose
tissue (SAT) [6]. Interestingly, VAT is related to an
increased CVD risk, while SAT is not [2, 3, 6, 7]. VAT
does not only provide storage of lipids but also functions as
an endocrine organ with adipocytes secreting bioactive
factors and pro-atherogenic cytokines (adipokines) [2, 8].
Consequently, measurement of VAT volume improves
accuracy of CVD risk profiling [3, 9]. However, the link
between abdominal obesity and CVD may also be influ-
enced by metabolic activity of VAT in the individual patient,
with inflammation caused by overproduction of adipokines
[10–14]. Therefore, it is likely that not only VAT volume
but also the metabolic activity of VAT is linked to CVD risk
[15] and may be useful for determining targets for treatment
to reduce CV risk.
Imaging modalities such as magnetic resonance imaging
(MRI) and X-ray computed tomography (CT) are both
reliable methods for the assessment of abdominal adipose
tissue volume [16] although both modalities are limited for
the assessment of metabolic activity. Previous studies have
assessed the metabolic activity of abdominal adipose tissue
with 2-deoxy-2-[18F]fluoro-D-glucose ([[18F]FDG) positron
emission tomography (PET) [17–27]. Overall, there is a
growing interest in quantifying VAT as a CV risk marker
and as a readout for therapeutic approaches [22, 28, 29].
The most common method to measure metabolic VAT
activity is by manually drawing regions of interest (ROIs).
However, the mean standardized uptake values (SUVmean)
in VAT measured by ROIs in different studies ranges from
0.22 to 0.88 [17, 26, 27] indicating a great variability with
this manual method. Consequently, there is a considerable
need for a robust (semi)automated method with good
accuracy and repeatability for assessment of VAT
[18F]FDG uptake on [18F]FDG -PET/CT scans. The
objective of this study is to evaluate the reproducibility
and repeatability of a semi-automated method for assess-
ment VAT [18F]FDG uptake using a [18F]FDG PET/CT




Prior to developing a semi-automated method for the
metabolic assessment of VAT, a literature search was
performed (details are described in Supplementary
material). The purpose of this search was to systematically
review published data on the [18F]FDG uptake reported
values and methods in VAT.
Study Design
To assess the reproducibility and repeatability of the
automated method, test-retest scans obtained from an
existing study in patients with non-small cell lung cancer
were used [30]. This study was approved by the institutional
review board and was registered in the Dutch trial register
(trialregister.nl, NTR3508). All procedures performed in this
study were in accordance with the Ethical Standards of the
institutional research committee and carried out according to
the principles of the Declaration of Helsinki. Written
informed consent for all subjects was obtained before study
enrolment.
Patients
Per patient, two whole-body [18F]FDG PET/low-dose (LD)
CT scans at 60 min uptake time were performed within
1 week. There were no significant differences in patient
preparation and PET acquisition between the test and retest
scan. In the current study, only scans obtained 60 min after
[18F]FDG injection were included as is recommended by
the European Association of Nuclear Medicine (EANM). In
addition, the reproducibility and repeatability of VAT
[18F]FDG uptake measurements was analyzed in 10
patients who had not received chemotherapy in the past
4 weeks and without known diabetes mellitus (60 % men,
median age 61 years (IQR, 45–66), weight 75 kg (IQR, 67–
77), median BMI 24.6 (IQR, 23.1–26.9), injected activity
test scan 248 Mbq (IQR, 194–377), injected activity retest
scan 238 Mbq (IQR, 192–392), test scan glucose 5.8 mmol/
L (IQR, 5.5–6.1), retest scan glucose 5.9 mmol/L (IQR,
5.4–6.4).
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PET/CT Imaging
All scans were performed on a Gemini TF PET/CT scanner
(Philips Healthcare, Best, Netherlands). Low-dose CT scans
were performed (120 keV; 50 mAs and pitch: 0.829). The
PET acquisition procedures and reconstruction conform to
the EANM recommendations [31]. Patients underwent a
low-dose (LD) CT during tidal breathing for attenuation
correction purposes, followed by a whole-body [18F]FDG
PET/CT scan (skull vertex to mid-thigh) 60 min after
[18F]FDG injection, using 2 min per bed position. Weight,
height, plasma glucose levels, total injected activity, time of
injection, residual activity, and scan start times were
recorded.
Data Analysis
All measurements were performed using MATLAB software
(version R2015b, The MathWorks, Inc., Natick, MA, USA).
PET and LDCT data were loaded into MATLAB and PET
data were realigned to match the LDCT. The quality of the
image fusion was visually verified and approved for all data
sets prior to the fat segmentation and analysis. In order to
analyze the entire abdomen, all slices from vertebral levels
L1 to L5 were manually selected. Two observers (SdB and
MR, both trained PhD students) independently analyzed all
PET/LDCT scans twice at different time points in order to
test both inter and intra observer variability. Both observers
were blinded to the prior analyses and results.
Adipose tissue was initially segmented by thresholding
the CT images between − 174 and − 24 Hounsfield Units
(HU) [18, 32–35] (refer to the supplementary material for
more details on fat segmentation). The abdominal muscular
layer was used as a boundary to separate VAT and SAT.
Because the abdominal muscular layer did not always totally
separate the VAT and SAT on the LDCT, for instance at the
linea alba, a line was manually drawn as a reference in all
slices in order to separate VAT and SAT.
The metabolic activity was expressed as SUV of
[18F]FDG [36]. High SUV inside VAT and SAT can be
due to overspill of metabolic active organs such as kidneys
and intestines. Therefore, the initial CT-based segmentation
was further adapted using an SUV threshold and a
morphological erosion in order to exclude spillover of signal
from [18F]FDG avid structures. Because in previously
studies SUVmean in VAT ranged from 0.22 to 0.89 [25, 27]
and SUVmax from 0.53 to 1.21 [17, 26], the effect of using
SUV thresholds ranging from 1.0 to 2.5 on VAT and SAT
uptake assessments were analyzed. In addition, the effects of
different erosions ranging from 0 to 5 pixels (pixel size of
1.17 × 1.17 mm2) on VAT and SAT uptake assessments
were analyzed. The mean and median SUV generated with
the automated method are referred to as ASUVmean and
ASUVmedian. The
ASUVmean in VAT and SAT were
compared with SUVmean assessed with a manual ROI
selection. For the manual method, all slices between L1
and L5, selected by the observers during the automated
method, were used. This area was divided into 4 equally
sized regions and ROIs were placed in the middle slice for
every region. On each of these slices, 3 ROIs (diameter
10.5 mm) were placed in both VAT and SAT. Observers
were instructed to place ROIs in homogeneous areas
covering the surface of the ROI, avoid spillover effects and
maximize the distance between ROIs. SUVmean across these
slices were averaged and referred to as MSUVmean. Further-
more, the percentage of VAT volume depicted with CT that
remained after thresholding and erosion was calculated. A
schematic overview of the semi-automated method is shown
in Fig. 1.
Criteria Optimal Settings for Automated
Metabolic Assessment of VAT
According to an expert panel, the optimal threshold and
erosion settings for the automated metabolic assessment of
VAT had to fulfill the following criteria: (1) highly
reproducible and repeatable (ICC 9 0.80), (2) the VAT
volume that remains for analysis should be as large as
possible (at least 50 % of the CT-based segmented VAT)
while ruling out spillover effects by visual inspection, (3)
The change in ASUVmedian /
ASUVmean VAT should be
smaller than 0.01 which was not considered as a relevant
difference.
Statistical Analysis
All analyses were performed using SPSS (Released 2013.
IBM SPSS Statistics for Windows, Version 22.0. Armonk,
NY: IBM Corp). For reproducibility analysis, only the
measurements of the first (test) [18F]FDG-PET/LDCT scan
performed were used as the second (retest) scan is related
with the first scan and can therefore not been used as an
independent measurement. For the repeatability analysis
(test-retest), measurements of the same observer were used
to exclude the intra-observer variability.
The influence of threshold and erosion on ASUVmean
VAT was evaluated using a generalized estimating equations
approach with an unstructured covariance matrix. ASUVmean
VAT was used as the dependent variable in the model,
erosion, and threshold were used as factors. An interaction
between erosion and threshold was also added in the model.
Effects were evaluated and compared with appropiate
correction for pairwise comparisons. Effect of threshold
and erosion on ASUVmedian VAT were analyzed similarly as
ASUVmean VAT.
The automated measurement of metabolic activity (with
the most optimal threshold and erosion settings) was
compared to manually placed ROIs with a Wilcoxon
signed-rank test. To explore whether the automated and
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manually measurement were correlated, a Spearman corre-
lation coefficient (r) was calculated.
The inter and intra observers reproducibility and the
repeatability were quantified using intraclass correlation
coefficients (ICCs; based on absolute agreement). Bland-
Altman plots [37] were used to evaluate the reproducibility
and repeatability. The measurement error for the reproduc-
ibility and repeatability were calculated according to the
formula of Bland and Altman [38]. The variation coeffi-
cients (%) were calculated as the measurement error divided
by the mean of the measurements.
Results
Semi-automated Metabolic Assessment of VAT
Threshold and Erosion
For every combination of threshold and erosion, the
reproducibility (inter and intra observers) and repeatability
for the ASUVmean VAT and
ASUVmedian VAT are calculated.
As a result of 16 thresholds and 6 sizes of erosion, each 3D
plot represents 96 ICCs (Suppl. Fig. 2 in Electronic
Supplementary Material (ESM)). Since the ICCs for
ASUVmean VAT and
ASUVmedian VAT were highly repro-
ducible and repeatable for all combinations of threshold and
erosion, both parameters could be used to report [18F]FDG
uptake (see also Suppl. Fig. 3).
The influence of the threshold and erosion on ASUVmean
VAT, ASUVmedian VAT, and percentage VAT volume
remaining after threshold and erosion are shown in Fig. 2.
In addition, see also supplemental Figs. 4 and 5 for an
example of the influence of different threshold and erosion
on the remaining abdominal adipose tissue analyzed.
ASUVmean VAT and
ASUVmedian VAT decreased signifi-
cantly for every increase in erosion (all p G 0.001) and
increased significantly for every 0.1 SUV increase in
threshold (all p G 0.001). According to the earlier described
criteria in this article (patients and methods), a SUV
threshold of 1.9 and an erosion of 1 turned out to be the
optimal setting for automated assessment of ASUVmean VAT
and as such was used for further analysis. For ASUVmedian
VAT a SUV threshold of ≥ 1.5 with an erosion of 1 or
maximal 2 turned out to be optimal (see also Fig. 2). For
further analysis, ASUVmedian VAT was defined as a SUV
threshold of 1.5 and an erosion of 2.
Reproducibility and Repeatability PET/CT Data
The characteristics of the PET/CT data for observer 1 and 2
are shown in Table 1. The reproducibility inter and intra
observers ICCs and the repeatability ICCs are shown in
Table 2. The automated assessment of SUVmean and
SUVmedian in VAT and SAT was significantly higher
compared to manual ROIs (both p G 0.01). The MSUVmean
VAT was correlated with ASUVmean VAT (r = 0.71, p =
0.02) and ASUVmedian VAT (r = 0.79, p G 0.01). The
MSUVmean SAT was correlated with
ASUVmean SAT (r =
0.79, p G 0.01) and ASUVmedian SAT (r = 0.86, p G 0.01).
The ASUVmean VAT correlated with
ASUVmedian VAT (r =
0.94, p G 0.01) and ASUVmean SAT correlated with
ASUVmedian SAT (r = 0.88, p G 0.01).
Figure 3 shows the intra observers reproducibility for
MSUVmean VAT and
ASUVmean VAT and corresponding
Bland-Altman plots. In addition, the intra observers mean
MSUVmean VAT was 0.48, with a measurement error of
0.091 SUV and variation coefficient of 19.2 %. The mean
ASUVmean VAT was 0.73 with a measurement error of 0.004
SUV and variation coefficient of 0.6 %. The mean
ASUVmedian VAT was 0.60 with a measurement error of
0.003 SUV and variation coefficient of 0.5 %.
Figure 4 shows the repeatability, test-retest data, for
MSUVmean VAT and
ASUVmean VAT and corresponding
Bland-Altman plots. The mean MSUVmean VAT was 0.55
with a measurement error of 0.069 SUV and variation
coefficient of 12.6 %. The mean ASUVmean VAT was 0.73
with a measurement error of 0.019 SUV and variation
coefficient of 2.5 %. The mean ASUVmedian VAT was 0.60
with a measurement error of 0.010 SUV and variation
coefficient of 1.7 %.
Discussion
The present study assessed the reproducibility and repeat-
ability for the metabolic assessment of VAT and SAT using
[18F]FDG-PET/CT imaging using both manual and semi-
automated segmentation. The automated metabolic
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Fig. 1. Schematic overview of the most important steps of adipose tissue segmentation on CT and SUV analysis on [18F]FDG
PET/LDCT scan. SAT subcutaneous adipose tissue, SUV standardized uptake values, VAT visceral adipose tissue.
assessment of VAT was highly reproducible and repeatable.
Moreover, the ICCs concerning the automated metabolic
assessment of VAT were superior to the manual method.
The ICCs for automated and manually metabolic assessment
of SAT were also highly reproducible. However, the
repeatability of the automated metabolic assessment of
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Fig. 2. The influence of threshold and erosion on (a) ASUVmean VAT, (b)
ASUVmedian VAT, and (c) the percentage of VAT volume
for metabolic analysis. Pixel size is 1.17 × 1.17 mm2.
Fig. 3. Reproducibility. aMSUVmean VAT of observer 1 plotted against those of observer 2 and d corresponding Bland-Altman
plot. bASUVmean VAT of observer 1 plotted against those of observer 2 and e corresponding Bland-Altman plot. c
ASUVmedian
VAT of observer 1 plotted against those of observer 2 and f corresponding Bland-Altman plot. SD standard deviation, SUV
standardized uptake values, VAT visceral adipose tissue; ASUVmean = automated generated with the method with setting SUV
threshold 1.9, erosion; MSUVmean =manually generated by drawing regions of interest.
SAT was lower than the manual method and lower than the
automated metabolic assessment of VAT.
The present study investigated the repeatability of
[18F]FDG uptake in VAT and SAT with a semi-
automated segmentation which included a SUV threshold
and erosion approach, with settings optimized for analysis
of VAT. As expected, the SUVmean/median in VAT
increased with higher SUV thresholds and decreased with
larger erosions. However, the increase in SUVmean/median
decreased with every 0.1 SUV increase in threshold. As a
difference of G 0.01 SUV was not considered relevant, this
was used as a criteria to assess the most optimal threshold.
In addition, since SUV in VAT are almost normally
distributed (Suppl Fig. 3), the ASUVmean as well as
ASUVmedian are reliable parameters. As both parameters
were highly reproducible and repeatable, we report both
parameters. Overall, SUVmean is the most common param-
eter used to report [18F]FDG uptake in VAT [18, 20, 23–
25, 27, 29].
Another criterion for the optimal threshold and erosion
was that at least 50 % of the CT-based segmented VAT
should remain for SUV analysis. This was based on the
assumption that not more than 50 % of the CT-based
segmented VAT would be influenced by spillover effects.
Based on the results of this study, we suggest that for
automated assessment of the metabolic activity of VAT, a
SUV threshold should optimally be 1.9 for ASUVmean or 1.5
for ASUVmedian and an erosion should be 1 pixel and
maximal 2 pixels.
The method was not fully automated since two manual
actions were needed; selection of the slices corresponding to
vertebral levels L1 to L5 and drawing a line to close the
abdominal muscular layer to separate VAT and SAT.
However, these manual actions barely affect the outcomes
as VAT and SAT volume measurements were highly
reproducible and repeatable (all ICC 9 0.97).
In order to improve CVD risk management associated
with obesity, VAT is recognized as an important contributor.
Clearly, VAT volume and metabolic activity are both linked
to the CVD risk and have become targets of imaging
modalities [3, 9, 15, 39]. Although, a note of caution is due
here since the interaction of insulin resistance which is
common in obesity, with [18F]FDG uptake in VAT is not
fully understood. In addition, some studies showed a
decreased [18F]FDG VAT uptake in obese subjects which
suggest an inverse association with insulin resistance and
CVD risk [18, 20]. However, with the availability of an
automated method of VAT and SAT including the repro-
ducibility and repeatability, this interaction can very well be
taken into account for future studies.
Two other studies used an automated method, in which a
VOI generated on CT was transferred to PET, to report
[18F]FDG uptake in VAT [23, 27]. Interestingly, one of this
studies showed that VAT [18F]FDG uptake was associated
with the degree of intestinal uptake on PET/CT [27]. Those
findings confirm the need for a threshold and erosion for the
automated metabolic assessment of VAT to overcome
overspill effects from surrounding organs.
The ASUVmean VAT/
ASUVmedian VAT was higher
compared with MSUVmean VAT. This result may be
explained by the fact that manual ROIs were placed in the
low [18F]FDG uptake areas, in an attempt to avoid spillover,
Table 1. PET/CT data characteristics for both observers
PET/CT data characteristics Observer 1 Observer 2
Distance L1–L5 (cm) 15.8 (15.0–16.1) 15.5 (15.0–16.5)
VAT volume (cm3) 2406 (1711–3869) 2344 (1646–3921)
SAT volume (cm3) 1986 (1700–3049) 2056 (1724–3135)
MSUVmean VAT 0.49 (0.44–0.59) 0.44 (0.38–0.49)
ASUVmean VAT 0.73 (0.67–0.81) 0.73 (0.67–0.82)
ASUVmedian VAT 0.59 (0.54–0.69) 0.60 (0.55–0.70)
MSUVmean SAT 0.32 (0.29–0.34) 0.30 (0.27–0.36)
ASUVmean SAT 0.37 (0.35–0.40) 0.37 (0.35–0.39)
ASUVmedian SAT 0.36 (0.31–0.37) 0.35 (0.30–0.36)
Data presented as median and interquartile distance. ASUVmean = automated
generated with the method with setting SUV threshold 1.9, erosion 1.
ASUVmedian = automated generated with the method with setting SUV
threshold 1.5, erosion 2. MSUVmean = manually generated by drawing
regions of interest
L lumbar vertebral body, SAT subcutaneous adipose tissue, SUV standard-
ized uptake values, VAT visceral adipose tissue
Table 2. Intra class correlation coefficients of PET/LDCT data reproducibility and repeatability
Inter observer 1 reproducibility Inter observer 2 reproducibility Intra observers reproducibility Repeatability
Distance L1–L5 (cm) 1.00 0.99 [0.97–0.99]* 0.97 [0.92–0.96]* 0.97 [0.89–0.99]*
VAT volume (cm3) 1.00 [0.99–1.00]* 1.00 [1.00–1.00]* 1.00 [0.99–1.00]* 1.00 [0.99–1.00]*
SAT volume (cm3) 1.00 [1.00–1.00]* 1.00 [1.00–1.00]* 1.00 [0.97–1.00]* 1.00 [0.98–1.00]*
MSUVmean VAT 0.92 [0.68–0.98]* 0.97 [0.89–0.99]* 0.57 [−0.29–0.82]‡ 0.78 [0.20–0.94]‡
ASUVmean VAT 1.00 [1.00–1.00]* 1.00 [1.00–1.00]* 1.00 [0.94–1.00]* 0.98 [0.94–1.00]*
ASUVmedian VAT 1.00 [1.00–1.00]* 1.00 1.00 [0.98–1.00]* 0.99 [0.98–1.00]*
MSUVmean SAT 0.95 [0.80–0.90]* 0.91 [0.66–0.98]* 0.91 [0.64–0.98]* 0.79 [−0.01–0.95]‡
ASUVmean SAT 0.97 [0.88–0.99]* 1.00 [1.00–1.00]* 0.99 [0.96–1.00]* 0.70 [−0.23–0.93]‡
ASUVmedian SAT 1.00 [0.99–1.00]* 1.00 1.00 [0.99–1.00]* 0.98 [0.93–1.00]*
Data presented as intra class correlation coefficients and 95 % confidence interval. ASUVmean = automated generated with the method with setting SUV
threshold 1.9, erosion 1. MSUVmean = manually generated by drawing regions of interest
L lumbar vertebral body, SAT subcutaneous adipose tissue, SUV standardized uptake values, VAT visceral adipose tissue
*P value G 0.001; ‡P value G 0.05
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and therefore potentially suffer from selection bias. Further-
more, the current study showed that automated measure-
ments of VAT were more accurate than manually drawn
ROIs, as the reproducibly, especially intra observers, and the
repeatability ICCs were much higher. A possible explanation
for this might be that the uptake of [18F]FDG in VAT is not
uniform. Therefore, the uptake in an ROI may be not
representative for the effective mean uptake of [18F]FDG in
the whole VAT region. However, it could be argued that in
the current study the SUVmean is still influenced by spillover
effects from other structures and may represent an overes-
timation of VAT activity. As the uptake of [18F]FDG in
VAT is almost normal distributed, it seems likeable that
SUVmean is a reliable parameter. Nevertheless, for a less
normal distribution SUVmedian can be used. In addition,
[18F]FDG uptake in VAT measured as SUVmedian is also
higher than measured with ROIs (0.59 vs.0.49 respectively).
It may be the case that ROIs are an underestimation of
[18F]FDG in VAT. As the combined volume of all ROIs is
approximately 0.1 % of the total VAT volume, it is unlikely
that ROIs reliable represent the overall [18F]FDG uptake in
VAT, let alone an adequate method for readout of
therapeutic approaches. Moreover, the automated measure-
ment variation coefficient of the reproducibility between
observers (0.6 %/0.5 %) and the repeatability (2.5 %/1.7 %)
was far less compared with manual ROIs (19.2 and 12.6 %,
respectively).
Our study also has some limitations. First, this study
included predominantly patients with a healthy BMI (G 25)
and no obese patients (BMI 9 30). Therefore, it is uncertain
if the automated method is also equally accurate in obese
subjects. Secondly, in the current study the settings were
optimized for analysis of VAT. As a result, the repeatability
of automated metabolic assessment of SAT was lower than
VAT. Thirdly, the [18F]FDG uptake in VAT was not
compared with levels of adipokines or macrophage infiltra-
tion. Therefore, the hypothesis that the inflammatory state
measured by [18F]FDG uptake in VAT is correlated with
macrophage infiltration or is positively associated with
adipokine levels could not be investigated. Further studies,
which take levels of adipokines and macrophage infiltration
in adipocytes into account, will need to be performed.
Finally, it is unclear if the optimal SUV threshold and level
of erosion found in this research are also optimal for other
vendors. This requires a sensitivity analysis, which was not
achievable within the scope of current study.
Conclusion
In summary, we conclude that a (semi-)automated method is
feasible and should be the preferred approach for metabolic
assessment of VAT in PET/CT [18F]FDG data. Furthermore,
the metabolic assessment of VAT may be useful for
determining targets for treatment to reduce CV risk.
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Fig. 4. Repeatability. aMSUVmean VAT of scan 1 (test) plotted against those of scan 2 (retest) and d corresponding Bland-
Altman plot. bASUVmean VAT of scan 1 (test) plotted against those of scan 2 (test-retest) and e corresponding Bland-Altman
plot. cASUVmedian VAT of scan 1 (test) plotted against those of scan 2 (test-retest) and f corresponding Bland-Altman plot. SD
standard deviation, SUV standardized uptake values, VAT visceral adipose tissue; ASUVmean = automated generated with the
method with setting SUV threshold 1.9, erosion; MSUVmean =manually generated by drawing regions of interest.
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